Can a patient with Attention Deficit Hyperactivity Disorder (ADHD) take clonidine and Vyvanse (lisdexamfetamine) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Clonidine and Vyvanse Be Taken Together?

Yes, clonidine and Vyvanse (lisdexamfetamine) can be taken together for ADHD treatment, as this combination is commonly used in clinical practice and has been studied for safety and efficacy. 1

Evidence Supporting Combined Use

The American Academy of Child and Adolescent Psychiatry guidelines explicitly address combining clonidine with stimulants (including amphetamines like lisdexamfetamine), noting that:

  • Clonidine has been combined with stimulants to reduce aggression, provide better ADHD symptom control after the stimulant wears off, and counteract stimulant-induced insomnia 1
  • Clinicians continue to use this combination despite historical concerns from four deaths reported to FDA MEDWATCH, with no further reports since 1
  • The rate of serious cardiovascular side effects (bradycardia, hypotension, hypertension) is rare to infrequent (less than 1/100) 1

Clinical Algorithm for Combined Therapy

Pre-Treatment Assessment

Before initiating the combination, you must:

  • Obtain complete cardiovascular history of the patient AND first-degree family members 1
  • A history of sudden death, repeated fainting, or arrhythmias in family members would likely rule out clonidine use 1
  • Measure baseline blood pressure and heart rate 2

Dosing Strategy

When combining these medications:

  • Start clonidine at 0.05 mg (half a tablet) at bedtime 1, 2
  • Increase the dose slowly, never exceeding 0.3-0.4 mg/day maximum 1, 2
  • Clonidine needs to be given at bedtime for sleep or 4 times daily for aggressive behavior control 1
  • Start medications sequentially rather than simultaneously when possible to identify which agent causes any adverse effects 3

Monitoring Requirements

  • Monitor blood pressure and heart rate at every visit, particularly during dose adjustments 2, 3
  • Watch for somnolence/sedation, fatigue, dry mouth, irritability, insomnia, and nightmares 2
  • The full therapeutic effect of clonidine may take 2-4 weeks to develop 2
  • ECGs at baseline are NOT advised based on largely negative findings from routine monitoring 1

Common Pitfalls and Critical Warnings

Discontinuation Risk

  • Never discontinue clonidine abruptly due to risk of rebound hypertension and potential hypertensive crisis 2, 4, 3
  • Clonidine must be tapered when discontinuing 3

Medication Errors

  • Be aware that compounding pharmacy errors with clonidine can cause severe toxicity (bradycardia, sedation, hypotension) 5
  • If unexplained sedation, bradycardia, or hypotension occurs, investigate potential dosing errors 5

Side Effect Profile

  • Sedation is the most common adverse effect with clonidine, making evening administration preferable 1, 6
  • The combination may have twice the rate of mild side effects (nausea, dry mouth, tremor) compared to either drug alone 1

Efficacy Considerations

Research evidence shows:

  • Methylphenidate (and by extension, other stimulants like lisdexamfetamine) offers superior efficacy for core ADHD symptoms compared to clonidine alone 6
  • Clonidine provides additional benefits for parent-rated symptoms, global functioning, and specific comorbidities (aggression, sleep disturbances, tics) 1, 7, 8, 6
  • The combination is particularly useful for ADHD with comorbid oppositional defiant disorder, conduct disorder, or autism spectrum disorder 7, 8

When to Consider This Combination

Clonidine as an adjunct to Vyvanse is most appropriate when:

  • Stimulant monotherapy provides inadequate symptom coverage throughout the day 1
  • Comorbid aggression, disruptive behavior disorders, or tics are present 1, 7, 8
  • Stimulant-induced insomnia or jaw clenching requires management 1, 2
  • Sleep disturbances need addressing 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clonidine for Stimulant-Induced Jaw Clenching

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safety Assessment of Combining Rexulti, Klonopin, and Adderall

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clonidine Overdose Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.

Journal of the American Academy of Child and Adolescent Psychiatry, 2008

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.